Fighting the (chemotherapeutic) resistance: restoring p53 function and silencing REV3L suppresses the cancerous metabolic phenotype in cisplatin treated human non-small lung carcinoma cells
Presented at 2nd World Congress on Cancer Research and Therapy (WCCRT 2017)
Recommended citation: Kong, L.*, Murata, M. M.*, & Digman, M. A. (2017, October). Fighting the (chemotherapeutic) resistance: restoring p53 function and silencing REV3L suppresses the cancerous metabolic phenotype in cisplatin treated human non-small lung carcinoma cells [Poster presentation]. 2nd World Congress on Cancer Research and Therapy (WCCRT 2017), San Diego, CA, United States.